{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:03:03Z","timestamp":1788436983591,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.amjcard.2023.11.039","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T19:58:05Z","timestamp":1701374285000},"page":"80-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4748-2751","authenticated-orcid":false,"given":"Jung Hahn","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron Shengting","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrija","family":"Mateti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Elbadawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam Y.","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Lopez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamas A.","family":"Mamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.11.039_bib0001","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network","volume":"105","author":"Smith","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0002","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/M15-2306","article-title":"Cardiovascular events associated with use of tyrosine kinase inhibitors in chronic myeloid leukemia: A population-based cohort study","volume":"165","author":"Dahl\u00e9n","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0003","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.clml.2016.01.006","article-title":"Mortality and vascular events among elderly patients with chronic myeloid leukemia: a retrospective analysis of linked SEER-Medicare data","volume":"16","author":"Lang","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0004","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/02841861003631495","article-title":"Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964\u20132003 followed up to the end of 2006","volume":"49","author":"Storm","year":"2010","journal-title":"Acta Oncol"},{"issue":"suppl 1","key":"10.1016\/j.amjcard.2023.11.039_bib0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/0284186X.2015.1115124","article-title":"Trends in hematological cancer in the elderly in Denmark, 1980\u20132012","volume":"55","author":"Ocias","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0006","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jaccao.2022.05.001","article-title":"How common is pre-existing cardiovascular disease in cancer patients: what do we know? does it matter?","volume":"4","author":"Mamas","year":"2022","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0007","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0008","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejca.2011.09.015","article-title":"Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden","volume":"48","author":"Z\u00f6ller","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0009","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/jth.14475","article-title":"Risk of thromboembolic and bleeding outcomes following hematological cancers: a Danish population-based cohort study","volume":"17","author":"Adelborg","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0010","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/ajh.24490","article-title":"Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: a nationwide population-based study","volume":"91","author":"Broesby-Olsen","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0011","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1016\/j.clml.2019.04.012","article-title":"A retrospective study of comorbidities and complications in elderly acute myeloid leukemia patients in the United States","volume":"19","author":"Dhopeshwarkar","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0012","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2147\/CLEP.S218063","article-title":"Cardiovascular diseases and psychiatric disorders during the diagnostic workup of suspected hematological malignancy","volume":"11","author":"Liu","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0013","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.ejca.2012.01.005","article-title":"Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden","volume":"48","author":"Z\u00f6ller","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0014","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of arterial thromboembolism in patients with cancer","volume":"70","author":"Navi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0015","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/CIRCULATIONAHA.116.025778","article-title":"Risk of cerebrovascular events in 178 962 five-year survivors of cancer diagnosed at 15 to 39 years of age: the TYACSS (Teenage and Young Adult Cancer Survivor Study)","volume":"135","author":"Bright","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0016","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","article-title":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases","volume":"394","author":"Strongman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0017","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-08-3392","article-title":"Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma","volume":"107","author":"Moser","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0018","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/joim.13303","article-title":"Myocardial infarction in diffuse large B-cell lymphoma patients \u2013 a population-based matched cohort study","volume":"290","author":"Ekberg","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0019","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","article-title":"Late cardiotoxicity after treatment for Hodgkin lymphoma","volume":"109","author":"Aleman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0020","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0021","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jacc.2022.04.042","article-title":"Cardiovascular disease risk among cancer survivors: the Atherosclerosis Risk In Communities (ARIC) study","volume":"80","author":"Florido","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0022","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.3399\/BJGP.2022.0088","article-title":"Cancer history as a predictor in cardiovascular risk scores: a primary care cohort study","volume":"73","author":"Strongman","year":"2022","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2022.106809","article-title":"Thrombotic events and mortality risk in patients with newly diagnosed polycythemia vera or essential thrombocythemia","volume":"115","author":"Pemmaraju","year":"2022","journal-title":"Leuk Res"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0024","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ehjqcco\/qcac016","article-title":"Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019","volume":"9","author":"Raisi-Estabragh","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0025","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41375-022-01596-z","article-title":"Changing causes of death in persons with haematological cancers 1975\u20132016","volume":"36","author":"Chen","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0026","doi-asserted-by":"crossref","first-page":"b4606","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0027","series-title":"StatPearls [Internet]","article-title":"Anthracycline medications (doxorubicin)","author":"Douedi","year":"2023"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0028","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/euhj.2000.2289","article-title":"Coronary artery disease as the cause of incident heart failure in the population","volume":"22","author":"Fox","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0029","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-125-1-199607010-00008","article-title":"Anthracycline-induced cardiotoxicity","volume":"125","author":"Shan","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/annonc\/mdg070","article-title":"Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma","volume":"14","author":"Limat","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0031","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0032","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/cancers14010087","article-title":"FDA-approved drugs for hematological malignancies-the last decade review","volume":"14","author":"Sochacka-\u0106wik\u0142a","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0033","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.7150\/ijbs.35460","article-title":"Radiation-induced heart disease: a review of classification, mechanism and prevention","volume":"15","author":"Wang","year":"2019","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1205836","article-title":"Radiation for hematologic malignancies: from cell killing to immune cell priming","volume":"13","author":"Dabaja","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.clml.2019.12.027","article-title":"Cardiotoxicity in hematopoietic stem cell transplant: keeping the beat","volume":"20","author":"Baker","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0036","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0037","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2174\/157016110791330799","article-title":"Thromboembolic complications in malignant haematological disorders","volume":"8","author":"Castelli","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0038","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1741-7015-10-97","article-title":"Intracranial hemorrhage in adult patients with hematological malignancies","volume":"10","author":"Chen","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0039","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/682054","article-title":"Mechanisms linking red blood cell disorders and cardiovascular diseases","volume":"2015","author":"Mozos","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0040","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/annonc\/mdt156","article-title":"Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma","volume":"24","author":"Maraldo","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0041","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ijrobp.2011.09.020","article-title":"Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma","volume":"83","author":"Maraldo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0042","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1053\/euhj.1998.1280","article-title":"Incidence and aetiology of heart failure; a population-based study","volume":"20","author":"Cowie","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0043","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(00)04235-5","article-title":"Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.11.039_bib0044","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(99)11180-2","article-title":"Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations","volume":"355","author":"Kuulasmaa","year":"2000","journal-title":"Lancet"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923013310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923013310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:52:02Z","timestamp":1757573522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923013310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":44,"alternative-id":["S0002914923013310"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.11.039","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.11.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}